Plasma pharmacokinetic parameters for each cytokine after intravenous administration of 4F to normal and irradiated monkeys
Pharmacokinetic parameters . | SCF . | . | FL . | . | MGDF . | . | IL-3 . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Unir . | After TBI* . | Unir . | After TBI* . | Unir . | After TBI* . | Unir . | After TBI* . | ||||
Elimination half-life, h | 4.2 | 6.3 ± 1.2 | 13.2 | 12.32 ± 4.9 | 6.15 | 4.9 ± 0.7 | 1.35 | 2.25 ± 1.3 | ||||
Clearance, mL/h/kg | 25.16 | 31.7 ± 5.6 | 4.46 | 7.75 ± 3.5 | 3.5 | 2.1 ± 0.7 | 70 | 220.2 ± 60 | ||||
Vc, mL/kg | 32.43 | 21.9 ± 2.3 | 65.52 | 46.5 ± 16.7 | 3.6 | 8.7 ± 3.5 | 7.2 | 111.2 ± 31 | ||||
Vd, mL/kg | 156 | 288 ± 57 | 75.95 | 116.6 ± 45 | 31.2 | 15.1 ± 3.3 | 138.9 | 723 ± 227 | ||||
AUC, μg/mL/h | 2 | 1.73 ± 0.5 | 9.2 | 5.48 ± 2.1 | 13.8 | 25.4 ± 4.4 | 0.8 | 0.27 ± 0.08 | ||||
Plasma level at 24 h, ng/mL | 2.5 | 0.65 ± 0.2 | 215 | 99.5 ± 45 | 80.7 | 87.3 ± 24 | < DT | < DT |
Pharmacokinetic parameters . | SCF . | . | FL . | . | MGDF . | . | IL-3 . | . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Unir . | After TBI* . | Unir . | After TBI* . | Unir . | After TBI* . | Unir . | After TBI* . | ||||
Elimination half-life, h | 4.2 | 6.3 ± 1.2 | 13.2 | 12.32 ± 4.9 | 6.15 | 4.9 ± 0.7 | 1.35 | 2.25 ± 1.3 | ||||
Clearance, mL/h/kg | 25.16 | 31.7 ± 5.6 | 4.46 | 7.75 ± 3.5 | 3.5 | 2.1 ± 0.7 | 70 | 220.2 ± 60 | ||||
Vc, mL/kg | 32.43 | 21.9 ± 2.3 | 65.52 | 46.5 ± 16.7 | 3.6 | 8.7 ± 3.5 | 7.2 | 111.2 ± 31 | ||||
Vd, mL/kg | 156 | 288 ± 57 | 75.95 | 116.6 ± 45 | 31.2 | 15.1 ± 3.3 | 138.9 | 723 ± 227 | ||||
AUC, μg/mL/h | 2 | 1.73 ± 0.5 | 9.2 | 5.48 ± 2.1 | 13.8 | 25.4 ± 4.4 | 0.8 | 0.27 ± 0.08 | ||||
Plasma level at 24 h, ng/mL | 2.5 | 0.65 ± 0.2 | 215 | 99.5 ± 45 | 80.7 | 87.3 ± 24 | < DT | < DT |
Unir indicates unirradiated monkeys (n = 2); after TBI, pharmacokinetic study performed over 24 hours after 4F was administered 2 hours after irradiation (n = 5); and DT, Elisa kit detection threshold.
Values given as mean ± SD.